Panacea Biotec Limited - Product Pipeline Review - 2014

Published: Mar, 2014 | Pages: 57 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Panacea Biotec Limited - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Panacea Biotec Limited - Product Pipeline Review - 2014', provides an overview of the Panacea Biotec Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Panacea Biotec Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Panacea Biotec Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Panacea Biotec Limited's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Panacea Biotec Limited's pipeline products

Reasons to buy

- Evaluate Panacea Biotec Limited's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Panacea Biotec Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Panacea Biotec Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Panacea Biotec Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Panacea Biotec Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Panacea Biotec Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Panacea Biotec Limited Snapshot 7
Panacea Biotec Limited Overview 7
Key Information 7
Key Facts 7
Panacea Biotec Limited - Research and Development Overview 8
Key Therapeutic Areas 8
Panacea Biotec Limited - Pipeline Review 12
Pipeline Products by Stage of Development 12
Pipeline Products - Monotherapy 13
Panacea Biotec Limited - Pipeline Products Glance 14
Panacea Biotec Limited - Late Stage Pipeline Products 14
Phase III Products/Combination Treatment Modalities 14
Panacea Biotec Limited - Clinical Stage Pipeline Products 15
Phase I Products/Combination Treatment Modalities 15
Panacea Biotec Limited - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
Panacea Biotec Limited - Unknown Stage Pipeline Products 18
Unknown Products/Combination Treatment Modalities 18
Panacea Biotec Limited - Drug Profiles 19
Hexavalent DTwP-Hepb-Hib-IPV Vaccine 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Pentavalent DTwP-Hib-IPV Vaccine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Nucovac 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
PBL-1427 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
bevacizumab biosimilar 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
cetuximab biosimilar 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
darbepoetin alfa biosimilar 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
etanercept biosimilar 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Hepatitis-B Mucosal Vaccine 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
omalizumab Biosimilar 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
rituximab biosimilar 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
trastuzumab biosimilar 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Long Acting GLP-1 Analogues for Diabetes 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Egg Based Viral Vaccine For Yellow Fever 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Fusion Protein For Autoimmune Disorders 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Human Monoclonal Antibody For Rheumatoid Arthritis 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Meningococcal Vaccine 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Monoclonal Antibodies For Cancer 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Peptide For Hair Regeneration 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Pertussis Vaccine 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Pneumococcal Conjugate CRM Vaccine 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Recombinant \Chimeric Recombinant Tetravalent Dengue Vaccine 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
Recombinant Protein for Anaemia with Chronic Renal Failure 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
Respiratory Syncytial Virus Vaccine 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
Universal Recombinant Influenza Vaccine 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Vero Cell Based Japanese Encephalitis Vaccine 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
Panacea Biotec Limited - Pipeline Analysis 45
Panacea Biotec Limited - Pipeline Products by Target 45
Panacea Biotec Limited - Pipeline Products by Route of Administration 47
Panacea Biotec Limited - Pipeline Products by Molecule Type 48
Panacea Biotec Limited - Pipeline Products by Mechanism of Action 50
Panacea Biotec Limited - Dormant Projects 51
Panacea Biotec Limited - Company Statement 52
Panacea Biotec Limited - Locations And Subsidiaries 54
Head Office 54
Other Locations & Subsidiaries 54
Appendix 56
Methodology 56
Coverage 56
Secondary Research 56
Primary Research 56
Expert Panel Validation 56
Contact Us 57
Disclaimer 57

List of Tables
Panacea Biotec Limited, Key Information 7
Panacea Biotec Limited, Key Facts 7
Panacea Biotec Limited - Pipeline by Indication, 2014 10
Panacea Biotec Limited - Pipeline by Stage of Development, 2014 12
Panacea Biotec Limited - Monotherapy Products in Pipeline, 2014 13
Panacea Biotec Limited - Phase III, 2014 14
Panacea Biotec Limited - Phase I, 2014 15
Panacea Biotec Limited - Preclinical, 2014 16
Panacea Biotec Limited - Discovery, 2014 17
Panacea Biotec Limited - Unknown, 2014 18
Panacea Biotec Limited - Pipeline by Target, 2014 46
Panacea Biotec Limited - Pipeline by Route of Administration, 2014 47
Panacea Biotec Limited - Pipeline by Molecule Type, 2014 49
Panacea Biotec Limited - Pipeline Products by Mechanism of Action, 2014 50
Panacea Biotec Limited - Dormant Developmental Projects,2014 51
Panacea Biotec Limited, Other Locations 54
Panacea Biotec Limited, Subsidiaries 55